These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30887312)

  • 1. Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma: A Narrative Review and Critical Appraisal of Current Regulations.
    Allen H; Backhouse SH; Hull JH; Price OJ
    Sports Med; 2019 May; 49(5):659-668. PubMed ID: 30887312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study.
    Brambilla C; Le Gros V; Bourdeix I;
    Clin Ther; 2003 Jul; 25(7):2022-36. PubMed ID: 12946548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta agonists in asthma therapy.
    Rissmiller RW; Larj MJ; Peters SP
    Curr Allergy Asthma Rep; 2004 Mar; 4(2):91-2. PubMed ID: 14769255
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of changes in anti-doping regulations (WADA Guidelines) on asthma care in athletes.
    Couto M; Horta L; Delgado L; Capão-Filipe M; Moreira A
    Clin J Sport Med; 2013 Jan; 23(1):74-6. PubMed ID: 22948449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?
    Lund TK
    Clin Respir J; 2009 Apr; 3(2):123. PubMed ID: 20298392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induced asthma and sport].
    Chenuel B
    Rev Prat; 2020 Nov; 70(9):997-1004. PubMed ID: 33739762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma medication in athletes: a qualitative investigation of adherence, avoidance and misuse in competitive sport.
    Allen H; Price OJ; Hull JH; Backhouse SH
    J Asthma; 2022 Apr; 59(4):811-822. PubMed ID: 33504234
    [No Abstract]   [Full Text] [Related]  

  • 16. In athletes with mild intermittent asthma, is a beta-2 agonist 15-30 minutes prior to activity more effective at preventing an asthma attack than a daily inhaled steroid?
    Al-Kazaz A; Green M; Canillas M; Welborn TL
    J Okla State Med Assoc; 2012 Nov; 105(11):425-6. PubMed ID: 23304899
    [No Abstract]   [Full Text] [Related]  

  • 17. Doping taboos.
    Wolstenholme RJ
    Br J Sports Med; 1995 Dec; 29(4):279. PubMed ID: 8808548
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of anti-asthmatic medication among Danish elite athletes].
    Lund TK; Pedersen L; Backer V
    Ugeskr Laeger; 2007 Dec; 169(50):4355-9. PubMed ID: 18211794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing medications and nutritional supplements for athletes.
    Babwah T
    West Indian Med J; 2009 Sep; 58(4):352-6. PubMed ID: 20099776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.